Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL1248212 | 1.00 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL624470 | 1.00 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL28740960 | 0.93 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL10770115 | 0.86 | TSHR (0.42) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL814834 | 0.85 | TSHR (0.67) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL4340516 | 0.85 | TSHR (0.67) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL4057767 | 0.85 | TSHR (0.67) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL8119298 | 0.85 | TSHR (0.67) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL2427604 | 0.81 | TSHR (0.61) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL28564114 | 0.81 | TSHR (0.61) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2912008-B1 | PROCESS FOR PREPARING 2-METHOXYMETHYL-1,4-BENZENEDIAMINE AND SALTS THEREOF | NOXELL CORP (US) | 2020-08-05 | — | — | EP | claimed |
| EP-3131152-A1 | FLAME RETARDANT BATTERY ELECTROLYTES CONTAINING PHOSPHORIC ACID ESTERS | LANXESS Deutschland GmbH (DE) | 2017-02-15 | — | — | EP | claimed |
| EP-1505057-B1 | METHOD OF PURIFYING QUATERNARY ALKYLAMMONIUM SALT | STELLA CHEMIFA KABUSHIKI KAISHA (JP) | 2011-06-22 | — | — | EP | claimed |
| EP-1289031-A2 | Method of manufactoring a structured conducting polymer layer | Technische Universität Braunschweig (DE) | 2003-03-05 | — | — | EP | claimed |
| US-12567751-B2 | Formation process for a potassium-ion hybrid super-capacitor | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2026-03-03 | — | — | US | disclosed |
| US-11608350-B2 | Compositions and methods comprising conductive metal organic frameworks and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-03-21 | — | — | US | disclosed |
| US-20230077860-A1 | FORMATION PROCESS FOR A POTASSIUM-ION HYBRID SUPER-CAPACITOR | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2023-03-16 | — | — | US | disclosed |
| US-20210009617-A1 | COMPOSITIONS AND METHODS COMPRISING CONDUCTIVE METAL ORGANIC FRAMEWORKS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-01-14 | — | — | US | disclosed |
| US-10822364-B2 | Compositions and methods comprising conductive metal organic frameworks and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-11-03 | — | — | US | disclosed |
| EP-3293745-B1 | ADDITIVE MATERIAL FOR AN ELECTRODE OF AN ELECTROCHEMICAL CELL, DOUBLE LAYER CAPACITOR AND A METHOD FOR MANUFACTURING AN ELECTRODE OF THE SAME | HERAEUS BATTERY TECH GMBH (DE) | 2019-08-14 | — | — | EP | disclosed |
| US-20190211043-A1 | COMPOSITIONS AND METHODS COMPRISING CONDUCTIVE METAL ORGANIC FRAMEWORKS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2019-07-11 | — | — | US | disclosed |
| EP-3337801-B1 | METHOD FOR THE PREPARATION OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1-6-NAPHTHYRIDINE-3-CARBOXAMIDE AND RECOVERY OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1-6-NAPHTHYRIDINE-3-CARBOXAMIDE BY ELECTROCHEMICAL METHODS | Bayer Pharma AG (DE) | 2019-06-12 | — | — | EP | disclosed |
| US-6469888-B1 | Non-aqueous electrolyte electric double-layer capacitor | BRIDGESTONE CORPORATION (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-1133514-A1 | METHOD FOR THE ELECTROCHEMICAL DETECTION OF NUCLEIC ACID OLIGOMER HYBRIDS | Friz Biochem GmbH (DE) | 2001-09-19 | — | — | EP | disclosed |
| EP-1101230-A1 | CHARGE STORAGE DEVICES | Energy Storage Systems Pty, Ltd (AU) | 2001-05-23 | — | — | EP | disclosed |
| WO-2000031101-A1 | METHOD FOR THE ELECTROCHEMICAL DETECTION OF NUCLEIC ACID OLIGOMER HYBRIDS | FRIZ BIOCHEM GMBH (DE) | 2000-06-02 | — | — | WO | disclosed |
| US-6064560-A | Active carbon and process for its production | MITSUBISHI CHEMICALS CORPORATION (JP) | 2000-05-16 | — | — | US | disclosed |
| WO-1999053510-A1 | CHARGE STORAGE DEVICES | ENERGY STORAGE SYSTEMS PTY. LTD. (AU) | 1999-10-21 | — | — | WO | disclosed |
| EP-0009697-B1 | PROCESS FOR PREPARING N-(ALPHA-METHOXY-ALKYL) URETHANES AND N-(ALPHA-METHOXY-ALKYL) URETHANES | BAYER AG (DE) | 1981-09-23 | — | — | EP | disclosed |
| EP-0009697-A2 | Process for preparing N-(alpha-methoxy-alkyl) urethanes and N-(alpha-methoxy-alkyl) urethanes | BAYER AG (DE) | 1980-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190211043-A1 | COMPOSITIONS AND METHODS COMPRISING CONDUCTIVE METAL ORGANIC FRAMEWORKS AND USES THEREOF | ILK, AOC1, OCIAD2 | TSHR 4769/4885NFKB1 4078/4885KCNA1 133/4885 |
| US-10822364-B2 | Compositions and methods comprising conductive metal organic frameworks and uses thereof | ILK, AOC1, OCIAD2 | TSHR 4769/4885NFKB1 4078/4885KCNA1 133/4885 |
| US-12567751-B2 | Formation process for a potassium-ion hybrid super-capacitor | KCNK10, KCNJ8, KCNH2 | TSHR 4040/4885NFKB1 1653/4885KCNA1 46/4885 |
| US-11608350-B2 | Compositions and methods comprising conductive metal organic frameworks and uses thereof | ILK, AOC1, OCIAD2 | TSHR 4769/4885NFKB1 4078/4885KCNA1 133/4885 |
| US-20210009617-A1 | COMPOSITIONS AND METHODS COMPRISING CONDUCTIVE METAL ORGANIC FRAMEWORKS AND USES THEREOF | ILK, AOC1, OCIAD2 | TSHR 4769/4885NFKB1 4078/4885KCNA1 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.